dihydroxyphenylalanine has been researched along with Ataxias, Hereditary in 3 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two subjects presented with action tremor around age 10-12 years and developed tremor-dominant parkinsonism with prominent neuropsychiatric features later in their 20s." | 1.72 | WARS2 mutations cause dopa-responsive early-onset parkinsonism and progressive myoclonus ataxia. ( Berutti, R; Bonifati, V; Boumeester, V; Brunet, T; Gdovinova, Z; Han, V; Havrankova, P; Houlden, H; Jech, R; Kaiyrzhanov, R; Kuipers, DJS; Kulcsarova, K; Lackova, A; Mandemakers, W; Orec, L; Ostrozovicova, M; Pavelekova, P; Plecko, B; Rektorova, I; Rizig, M; Skorvanek, M; Steinfeld, R; Tijssen, MAJ; Wagner, M; Winkelmann, J; Zech, M, 2022) |
| "When all three categories of Parkinson's disease, MSA, and SRO were considered together, clinical and 18F-dopa PET findings correlated in 64% of patients assigned a diagnosis of Parkinson's disease and 70% of those given a diagnosis of SRO; MSA was less readily discriminated, patients with MSA being assigned to MSA, Parkinson's disease, and SRO groups with equal frequency." | 1.29 | Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. ( Brooks, DJ; Burn, DJ; Sawle, GV, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Skorvanek, M | 1 |
| Rektorova, I | 1 |
| Mandemakers, W | 1 |
| Wagner, M | 1 |
| Steinfeld, R | 1 |
| Orec, L | 1 |
| Han, V | 1 |
| Pavelekova, P | 1 |
| Lackova, A | 1 |
| Kulcsarova, K | 1 |
| Ostrozovicova, M | 1 |
| Gdovinova, Z | 1 |
| Plecko, B | 1 |
| Brunet, T | 1 |
| Berutti, R | 1 |
| Kuipers, DJS | 1 |
| Boumeester, V | 1 |
| Havrankova, P | 1 |
| Tijssen, MAJ | 1 |
| Kaiyrzhanov, R | 1 |
| Rizig, M | 1 |
| Houlden, H | 1 |
| Winkelmann, J | 1 |
| Bonifati, V | 1 |
| Zech, M | 1 |
| Jech, R | 1 |
| Eckert, T | 1 |
| Feigin, A | 1 |
| Lewis, DE | 1 |
| Dhawan, V | 1 |
| Frucht, S | 1 |
| Eidelberg, D | 1 |
| Burn, DJ | 1 |
| Sawle, GV | 1 |
| Brooks, DJ | 1 |
3 other studies available for dihydroxyphenylalanine and Ataxias, Hereditary
| Article | Year |
|---|---|
WARS2 mutations cause dopa-responsive early-onset parkinsonism and progressive myoclonus ataxia.
Topics: Ataxia; Dihydroxyphenylalanine; Humans; Mutation; Myoclonus; Parkinsonian Disorders; Phenotype; Spin | 2022 |
Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging.
Topics: Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Ganglia; Humans; Male; Middle Aged | 2007 |
Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.
Topics: Adult; Aged; Analysis of Variance; Caudate Nucleus; Corpus Striatum; Diagnosis, Differential; Dihydr | 1994 |